Citius Oncology Inc (TENKU) Inventory Turnover Ratio, from third quarter 2026 to third quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Citius Oncology Inc  (NASDAQ: TENKU)
 

Citius Oncology Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Citius Oncology Inc inventory turnover ratio, the Citius Oncology Inc's ability to sell and replace its inventory in the third quarter 2026, sequentially increased to 0.07 in the third quarter 2026, TENKU's markets remain strong, its supply chain continue to be in a grate shape.Average inventory processing period, for the Citius Oncology Inc in Jun 30 2026 quarter, has decreased to 5214 days, compare to 7300 days, in the Mar 31 2026 quarter.

Within Healthcare sector 378 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1619 in the second quarter 2026, to 1962.

TENKU Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Citius Oncology Inc Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TENKU Inventory Turnover Ratio (Jun 30 2026)
III. Quarter		 (Mar 31 2026)
II. Quarter		 (Dec 31 2025)
2025		 (Sep 30 2025)
IV. Quarter		 (Jun 30 2025)
III. Quarter
Y / Y Inventory Growth 31.48 % 47.72 % 57.42 % 169.53 % -
Y / Y Cost of Sales Growth - - - - -
Inventory Turnover Ratio (TTM) 0.07 0.05 0.04 - -
TENKU's Total Ranking # 1962 # 1619 # 0 # 0 # 0
Average inventory processing period 5113 6920 8958 - -
Seq. Inventory Growth -0.15 % 0.09 % 1.58 % 29.51 % 12.19 %
Seq. Cost of Sales Growth 49.55 % -58.33 % - - -




Inventory Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 121
Healthcare Sector # 379
Overall Market # 1962

Inventory Turnover Ratio Statistics
High Average Low
0.04 0.03 0.02
(Jun 30 2026)   (Mar 31 2026)



TENKU Company Profile >> Back to TENKU Efficiency Comparisons >> Compare TENKU Inventory Turnover Ratio to its Competitors

Financial Statements
Citius Oncology Inc's Inventories $ 23 Millions Visit TENKU's Balance sheet
Citius Oncology Inc's Cost of Revenues TTM $ 2 Millions Visit TENKU's Income Statement
What are TENKU's Sales? Visit TENKU's Sales by Segment

Other Inventory Turnover Ratios
Citius Oncology Inc's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Major Pharmaceutical Preparations Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TENKU's Inventory Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TENKU's Competitors
Inventory Turnover Ratio for TENKU's Suppliers
Inventory Turnover Ratio for TENKU's Customers

You may also want to know
TENKU's Sales Growth Rates TENKU's Pe Price to earnings ratio TENKU's Receivables Turnover Ratio TENKU's Stock Quote
TENKU's Net Income Growth Rates TENKU's Ps Price to Sales ratio TENKU's Sales per Employee TENKU's Asset Turnover Ratio
TENKU's Net Margin TENKU's Pb Price to Book ratio TENKU's Financial Strength Ratios TENKU's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Verrica Pharmaceuticals Inc   0.17 $ 0.400  Millions$ 2  Millions
Nexalin Technology Inc   0.17 $ 0.030  Millions$ 0  Millions
Femasys Inc   0.15 $ 0.898  Millions$ 6  Millions
Yubo International Biotech Limited  0.15 $ 0.004  Millions$ 0  Millions
Bioadaptives Inc   0.14 $ 0.006  Millions$ 0  Millions
Madrigal Pharmaceuticals Inc   0.12 $ 10.400  Millions$ 89  Millions
Citius Pharmaceuticals Inc   0.07 $ 1.610  Millions$ 22  Millions
Ptc Therapeutics inc   0.05 $ 3.600  Millions$ 75  Millions
Adagio Medical Holdings inc   0.05 $ 0.089  Millions$ 2  Millions
Citius Oncology Inc  0.04 $ 0.821  Millions$ 21  Millions
Vireo Growth Inc.  0.03 $ 2.485  Millions$ 85  Millions

Date modified: 2026-08-17T17:22:22+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.